Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma.
Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma.
复制标题
以谷氨酰胺酶1为靶点并与临床药物协同，对多发性骨髓瘤取得了更有前景的抗肿瘤活性。
DOI：
10.18632/oncotarget.27243
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Hu Yiguo
中科院分区：
文献类型：
--
作者：
Qiu Qiang;Li Mengyuan;Yang Linyu;Tang Minghai;Zheng Li;Wang Fang;Qiu Hu;i;Liang Cailing;Li Ning;Yi Dongni;Yi Yuyao;Pan Cong;Yang Shengyong;Chen Lijuan;Hu Yiguo
